Phase 1 trial of adavosertib (AZD1775) in combination with concurrent radiation and cisplatin for intermediate‐risk and high‐risk head and neck squamous cell carcinoma-Reference-Cited by-同舟云学术

Phase 1 trial of adavosertib (AZD1775) in combination with concurrent radiation and cisplatin for intermediate‐risk and high‐risk head and neck squamous cell carcinoma

Published:2021-08-11 Issue:23 Volume:127 Page:4447-4454
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Chera Bhishamjit S.¹²^ORCID,Sheth Siddharth H.²³^ORCID,Patel Shetal A.²³,Goldin Dan²,Douglas Kathe E.²^ORCID,Green Rebecca L.¹,Shen Colette J.²³,Gupta Gaorav P.¹²,Moore Dominic T.²,Grilley Olson Juneko E.²³,Weiss Jared M.²³^ORCID

Affiliation:

1. Department of Radiation Oncology University of North Carolina School of Medicine Chapel Hill North Carolina

2. Lineberger Comprehensive Cancer Center University of North Carolina Hospitals Chapel Hill North Carolina

3. Department of Medicine Division of Oncology University of North Carolina School of Medicine Chapel Hill North Carolina

Funder

School of Medicine, University of North Carolina at Chapel Hill

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cncr.33789